Clarametyx Biosciences
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $28M
Investors
- 9
About Clarametyx Biosciences
Based in Ohio, US, and founded in 2020 by CEO David Richards, Clarametyx Biosciences Inc. operates as a pharmaceutical research and development company developing vaccine that enables the human body to prevent the biofilm barrier to develop. In January 2024, Clarametyx Biosciences Inc. Clarametyx Biosciences Inc. developed a technology platform, which is a pathogen-agnostic that can be applied to a wide range of bacterial infections, known as CMTX-101. The company is also developing CMTX-301, which is a vaccine in pre-clinical development aimed at preventing biofilm formation by triggering an immune response to key biofilm proteins. In addition, the firm focuses on developing new treatments against persistent bacterial infections, with initial applications targeting respiratory tract infections and chronic diseases like cystic fibrosis.
Who invested in Clarametyx Biosciences
9 investors across 3 rounds
See all investors in Clarametyx Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clarametyx Biosciences
Who invested in Clarametyx Biosciences?
Clarametyx Biosciences has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clarametyx Biosciences raised?
Clarametyx Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Clarametyx Biosciences last raise money?
Clarametyx Biosciences's most recent round on record is a Series A, in Jan 2025.
What does Clarametyx Biosciences do?
Based in Ohio, US, and founded in 2020 by CEO David Richards, Clarametyx Biosciences Inc.
Where is Clarametyx Biosciences headquartered?
Clarametyx Biosciences is headquartered in Columbus, US.
Which VCs invest in companies like Clarametyx Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Clarametyx Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Clarametyx Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.